Time in range improved from 69.4% to 74.2%, daily insulin use fell by 11.3 units, and participants reduced carbohydrate intake and body weight with no increase in hypoglycemia
Retatrutide activates all three: GLP-1, which helps regulate appetite, fullness, insulin release, and blood sugar GIP, which plays a role in insulin signaling, metabolism, and appetite Glucagon, which may increase energy expenditure and support fat metabolism Early phase 3 trial data reported an average weight loss of 28.7% at 68 weeks, a figure that would represent a meaningful jump beyond current options
Wear compression stockings daily to improve blood flow
"GLP-1 friendly" labels arent regulated by the Food and Drug Administration, says Caroline Susie, RDN, LD , a spokesperson for the Academy of Nutrition and Dietetics
However, a key difference between Trulicity and Ozempic is that Trulicity is approved for use in treating type 2 diabetes in children over 10 years old, while Ozempic isnt approved for use in children